Portfolio news 0

Pfizer obesity royalty interest

Robust Phase 2b efficacy and favorable tolerability support monthly dosing for Pfizer’s GLP-1 RA Berobenatide

Oxford Quantum Circuits Limited

OQC raises £260m in Europe’s largest ever private quantum computing funding round

Genomics

Genomics launches the Mystra AI platform, adopted by industry giants and up-and-coming biotechs 

Audioscenic Ltd

Audioscenic™ to showcase next-generation spatial audio platform at COMPUTEX Taipei 2026

Audioscenic Ltd

Audioscenic™ brings true spatial audio technology to latest Lenovo™ Legion™ 7a Laptop

Slamcore

Slamcore secures $14m, backed by investors including Rockwell Automation , to scale visual AI across intralogistics

Oxford Nanopore Technologies Plc

Oxford Nanopore - London Calling Technology Update

Oxford Nanopore Technologies Plc

Oxford Nanopore strengthens executive leadership team

Microbiotica Ltd

Microbiotica announces positive Results from its Phase 1b Trial (MELODY-1) of MB097, a precision microbiome co-therapy in advanced melanoma

Atisama Therapeutics

Atisama Therapeutics advances RB042 into multiple ascending dose cohorts of Phase 1 trial and appoints Bernard Coulie as Chair of the Board